speb/financial-data huggingface dataset:
Financial ratios for XELB — quarterly report dated 2025-09-30
Total revenue: 1118000
Gross profit: 1118000
Operating income: -1948000
Net income: -7899000
Capital expenditures: 0
Operating cash flow: -1398000
Depreciation & amortization: 896000
Net tangible assets: -13412000
Owner earnings: -7003000
Buffett classification: The Gruesome
Stock price: 1.76
Shares outstanding: 6056121
Book value: 16580000
P/B ratio: 0.6428692979493366
Market cap (USD): 10658772.96
Debt to equity: 1.1039806996381183
Current ratio: 0.5121859767529059
Quick ratio: 0.5121859767529059
Interest coverage ratio: -3.731800766283525
COGS to revenue (%): 0
SG&A to revenue (%): 194.09660107334525
Free cash flow (dilution-adjusted): -1506000
Buyback yield (%): 0.056291657796977784
Retained earnings: -90928000
Receivables turnover: 0.796863863150392
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.001047410739041
FCF margin (%): -134.70483005366728
Revenue growth (%): -15.367146101438303
Rule of 40 score: -150.07197615510557
Financial ratios for XELB — quarterly report dated 2025-12-31
Total revenue: 1168000
Gross profit: 1168000
Operating income: -1948000
Net income: -2777000
Capital expenditures: 0
Operating cash flow: -1827000
Depreciation & amortization: 898000
Net tangible assets: -13268000
Owner earnings: -1879000
Buffett classification: The Gruesome
Stock price: 1.08
Shares outstanding: 6056121
Book value: 15824000
P/B ratio: 0.413334850859454
Market cap (USD): 6540610.680000001
Debt to equity: 1.1419994944388272
Current ratio: 0.49011752136752135
Quick ratio: 0.49011752136752135
Interest coverage ratio: -2.2998819362455727
COGS to revenue (%): 0
SG&A to revenue (%): 189.8972602739726
Free cash flow (dilution-adjusted): -2051000
Buyback yield (%): 1.2537055637746657
Retained earnings: -93705000
Receivables turnover: 1.2217573221757323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.192383495454257
FCF margin (%): -175.59931506849315
Revenue growth (%): 4.47227191413238
Rule of 40 score: -171.12704315436076
Financial ratios for XELB — annual report dated 2025-12-31
Total revenue: 4939000
Gross profit: 4939000
Operating income: -7221000
Net income: -17461000
Capital expenditures: 10000
Operating cash flow: -7023000
Depreciation & amortization: 3593000
Net tangible assets: -13268000
Owner earnings: -13878000
Buffett classification: The Gruesome
Stock price: 1.08
Shares outstanding: 6056121
Book value: 15824000
P/B ratio: 0.413334850859454
Market cap (USD): 6540610.680000001
Debt to equity: 1.1419994944388272
Current ratio: 0.49011752136752135
Quick ratio: 0.49011752136752135
Interest coverage ratio: -2.988824503311258
COGS to revenue (%): 0
SG&A to revenue (%): 173.4561652156307
Free cash flow (dilution-adjusted): -7603000
Buyback yield (%): 3.1189748171955096
Retained earnings: -93705000
Receivables turnover: 5.166317991631799
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.954415411024222
FCF margin (%): -153.93804413848957
Revenue growth (%): -40.19857125559995
Rule of 40 score: -194.13661539408952
Financial ratios for ZEN.V — annual report dated 2022-03-31
Total revenue: 271732.8
Gross profit: -29696.8
Operating income: -9587980
Net income: -25355238.4
Capital expenditures: 3188728
Operating cash flow: -6391097.6
Depreciation & amortization: 491768
Net tangible assets: 33239248.8
Owner earnings: -28052198.4
Return on net tangible assets (%): -84.39480256846237
Buffett classification: The Gruesome
Stock price: 3.088
Shares outstanding: 126619532
Book value: 33239248.8
P/B ratio: 11.763235600438719
Market cap (USD): 391001114.816
Debt to equity: 0.05369247694911806
Current ratio: 13.866117473102184
Quick ratio: 13.57734526651377
Interest coverage ratio: -187.92001818837514
COGS to revenue (%): 110.92867699445925
R&D to revenue (%): 453.94652393822173
SG&A to revenue (%): 2815.908863412882
Free cash flow (dilution-adjusted): -13614656
Buyback yield (%): 0
Retained earnings: -41743396.8
Inventory turnover: 0.5661100527065441
Receivables turnover: 0.09419039178473301
Capitalized R&D asset: 1233521.6
ROCI (R&D-adjusted, %): -24.777582237284953
FCF margin (%): -5010.310128184747
Rule of 40 score: -5010.310128184747
Financial ratios for ZEN.V — annual report dated 2023-03-31
Total revenue: 53966.666666666664
Gross profit: -578134.074074074
Operating income: -10854033.333333332
Net income: -10677234.074074073
Capital expenditures: 1683654.8148148146
Operating cash flow: -9597681.481481481
Depreciation & amortization: 399772.5925925926
Net tangible assets: 22506816.296296295
Owner earnings: -11961116.296296295
Return on net tangible assets (%): -53.14441695720691
Buffett classification: The Gruesome
Stock price: 1.5333333333333332
Shares outstanding: 126619532
Book value: 22506816.296296295
P/B ratio: 8.626273325855324
Market cap (USD): 194149949.06666666
Debt to equity: 0.05306046872647832
Current ratio: 7.419156729968948
Quick ratio: 6.241765289786256
Interest coverage ratio: -121.47619876641463
COGS to revenue (%): 1171.2799396060668
R&D to revenue (%): 2259.372726648823
SG&A to revenue (%): 15087.56434012765
Free cash flow (dilution-adjusted): -13654230.37037037
Buyback yield (%): 0
Retained earnings: -49035783.7037037
Inventory turnover: 0.29951356107758553
Receivables turnover: 0.020507226999563706
Capitalized R&D asset: 2045767.6201481482
ROCI (R&D-adjusted, %): -41.95747292623641
Rosenberg metric: -0.4446110016023019
FCF margin (%): -25301.229840093336
Revenue growth (%): -80.13980400354073
Rule of 40 score: -25381.369644096878
Financial ratios for ZEN.V — annual report dated 2024-03-31
Total revenue: 22085.925925925923
Gross profit: -223158.5185185185
Operating income: -8872976.296296297
Net income: -8669622.222222222
Capital expenditures: 229702.96296296295
Operating cash flow: -5964140
Depreciation & amortization: 454602.9629629629
Net tangible assets: 14943119.259259257
Owner earnings: -8444722.222222222
Return on net tangible assets (%): -56.512446134628746
Buffett classification: The Gruesome
Stock price: 1.1911764705882353
Shares outstanding: 126619532
Book value: 14943119.259259257
P/B ratio: 10.093354982885327
Market cap (USD): 150826207.2352941
Debt to equity: 0.06159569738302941
Current ratio: 3.4353706753805926
Quick ratio: 2.6536340766705293
Interest coverage ratio: -111.55987073100316
COGS to revenue (%): 1110.4105178427692
R&D to revenue (%): 5954.839683391468
SG&A to revenue (%): 30000.858599409712
Free cash flow (dilution-adjusted): -7725924.444444444
Buyback yield (%): 0
Retained earnings: -56756713.33333333
Inventory turnover: 0.23282995143398438
Receivables turnover: 0.035503987292106506
Capitalized R&D asset: 2539180.068740741
ROCI (R&D-adjusted, %): -49.1801895378952
Rosenberg metric: 0.2911286667727782
FCF margin (%): -34981.211430104646
Revenue growth (%): -59.074874751218175
Rule of 40 score: -35040.286304855865
Financial ratios for ZEN.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 114148.88888888888
Buffett classification: The Gruesome
Stock price: 0.6814814814814815
Shares outstanding: 126619532
Market cap (USD): 86288866.25185186
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZEN.V — quarterly report dated 2024-12-31
Total revenue: 26376.22377622378
Gross profit: -82339.86013986015
Operating income: -1819036.3636363638
Net income: -1819418.8811188813
Capital expenditures: 976.923076923077
Operating cash flow: -1226392.3076923077
Depreciation & amortization: 107555.24475524476
Net tangible assets: 11326530.069930071
Owner earnings: -1712840.5594405595
Return on net tangible assets (%): -15.122376834436235
Buffett classification: The Gruesome
Stock price: 0.9230769230769231
Shares outstanding: 126619532
Book value: 11326530.06993007
P/B ratio: 10.319097488673478
Market cap (USD): 116879568
Debt to equity: 0.04689991404548194
Current ratio: 1.827130464903269
Quick ratio: 1.4821570333657466
Interest coverage ratio: -114.54586287375051
COGS to revenue (%): 412.1745585662018
R&D to revenue (%): 439.0609258179119
SG&A to revenue (%): 5210.689856302031
Free cash flow (dilution-adjusted): -1429244.7552447552
Buyback yield (%): 0.03125385493328538
Retained earnings: -57725594.40559441
Inventory turnover: 0.17191773020470136
Receivables turnover: 0.1487924763505251
Capitalized R&D asset: 115807.69230769231
ROCI (R&D-adjusted, %): -15.03257990142392
FCF margin (%): -5418.686038496208
Rule of 40 score: -5418.686038496208
Financial ratios for ZEN.V — quarterly report dated 2025-03-31
Total revenue: 4813.524475524476
Gross profit: -148491.5244755245
Operating income: -2185783.132867133
Net income: -1286483.216783217
Capital expenditures: 0.6993006993006994
Operating cash flow: -896895.1048951049
Depreciation & amortization: 97590.20979020979
Net tangible assets: 10314298.601398602
Owner earnings: -1188893.7062937065
Return on net tangible assets (%): -11.526655880725563
Buffett classification: The Gruesome
Stock price: 1.125874125874126
Shares outstanding: 126619532
Book value: 10314298.601398602
P/B ratio: 13.821362015809814
Market cap (USD): 142557654.90909094
Debt to equity: 0.04613556020100279
Current ratio: 1.2533405298879396
Quick ratio: 0.9986751797201778
COGS to revenue (%): 3886.25289467032
R&D to revenue (%): 2953.5661466671704
SG&A to revenue (%): 30913.466427635423
Free cash flow (dilution-adjusted): -1154991.6083916083
Buyback yield (%): 0
Retained earnings: -58638546.15384616
Inventory turnover: 0.30140990119536815
Receivables turnover: 0.005723025246415491
Capitalized R&D asset: 219761.78321678325
ROCI (R&D-adjusted, %): -20.001621474403017
Rosenberg metric: -0.5712199510884334
FCF margin (%): -23994.71768066084
Revenue growth (%): -81.75051699453843
Rule of 40 score: -24076.46819765538
Financial ratios for ZEN.V — annual report dated 2025-03-31
Total revenue: 5161.986013986015
Gross profit: -148491.5244755245
Operating income: -2185783.132867133
Net income: -7020739.860139861
Capital expenditures: 977.6223776223777
Operating cash flow: -4393315.384615385
Depreciation & amortization: 419805.5944055944
Net tangible assets: 10314298.601398602
Owner earnings: -6601911.888111888
Return on net tangible assets (%): -64.00737600535125
Buffett classification: The Gruesome
Stock price: 1.125874125874126
Shares outstanding: 126619532
Book value: 10314298.601398602
P/B ratio: 13.821362015809814
Market cap (USD): 142557654.90909094
Debt to equity: 0.04613556020100279
Current ratio: 1.2533405298879396
Quick ratio: 0.9986751797201778
Interest coverage ratio: -34.22653526493873
COGS to revenue (%): 8732.612265025115
R&D to revenue (%): 6308.259411187757
SG&A to revenue (%): 108562.85324128512
Free cash flow (dilution-adjusted): -5592298.601398601
Buyback yield (%): 0
Retained earnings: -58638546.15384616
Inventory turnover: 0.7263137613252373
Receivables turnover: 0.006137327529941925
Capitalized R&D asset: 1609174.75001295
ROCI (R&D-adjusted, %): -23.37479802382665
Rosenberg metric: 0.056773148872873165
FCF margin (%): -108336.18274529776
Revenue growth (%): -76.627712909575
Rule of 40 score: -108412.81045820733
Financial ratios for ZEN.V — quarterly report dated 2025-06-30
Total revenue: 42187.59124087591
Gross profit: 19851.094890510947
Operating income: -1315801.4598540145
Net income: -994414.5985401459
Capital expenditures: 1727690.510948905
Operating cash flow: -857459.8540145984
Depreciation & amortization: 98054.74452554743
Net tangible assets: 10210213.13868613
Owner earnings: -2624050.3649635036
Return on net tangible assets (%): -25.700250614956033
Buffett classification: The Gruesome
Stock price: 1.072992700729927
Shares outstanding: 126619532
Book value: 10210213.13868613
P/B ratio: 13.306464004268806
Market cap (USD): 135861833.6058394
Debt to equity: 0.13411967922200702
Current ratio: 1.6221263468390754
Quick ratio: 1.302929286678326
Interest coverage ratio: -29.482009682062017
COGS to revenue (%): 52.94565461875184
R&D to revenue (%): 243.60087893835322
SG&A to revenue (%): 2332.31828641625
Free cash flow (dilution-adjusted): -985054.01459854
Buyback yield (%): 0
Retained earnings: -61932439.41605839
Inventory turnover: 0.034293597392875234
Receivables turnover: 0.1465333431365341
Capitalized R&D asset: 236240.20320555358
ROCI (R&D-adjusted, %): -11.409077182373577
Rosenberg metric: 1.1840885850422553
FCF margin (%): -2334.9377995397685
Revenue growth (%): 776.4386979933076
Rule of 40 score: -1558.499101546461
Financial ratios for ZEN.V — quarterly report dated 2025-09-30
Total revenue: 4463.309352517986
Gross profit: 2143.1654676258995
Operating income: -1672482.0143884893
Net income: -1720280.5755395684
Capital expenditures: 0
Operating cash flow: -869697.1223021584
Depreciation & amortization: 97187.05035971224
Net tangible assets: 8407340.287769785
Owner earnings: -1623093.5251798562
Return on net tangible assets (%): -19.305671825142863
Buffett classification: The Gruesome
Stock price: 0.7625899280575541
Shares outstanding: 126619532
Book value: 8407340.287769785
P/B ratio: 11.485056687788155
Market cap (USD): 96558779.79856117
Debt to equity: 0.1615923495424476
Current ratio: 0.7899204446842348
Quick ratio: 0.5343894143168524
Interest coverage ratio: -36.1238443011421
COGS to revenue (%): 51.98259187620891
R&D to revenue (%): 4318.326885880078
SG&A to revenue (%): 29610.557704706644
Free cash flow (dilution-adjusted): -1152098.5611510791
Buyback yield (%): 0
Retained earnings: -62756070.503597125
Inventory turnover: 0.0036277409129308433
Receivables turnover: 0.027424630890283797
Capitalized R&D asset: 308512.0553161065
ROCI (R&D-adjusted, %): -16.350617177938602
Rosenberg metric: -0.1723075081988758
FCF margin (%): -25812.65312701483
Revenue growth (%): -89.42032663814793
Rule of 40 score: -25902.073453652978
Financial ratios for ZEN.V — quarterly report dated 2025-12-31
Total revenue: 47649.635036496344
Gross profit: -18181.021897810217
Operating income: -1741729.9270072991
Net income: -1816169.3430656933
Capital expenditures: 1474.4525547445255
Operating cash flow: -1423923.3576642335
Depreciation & amortization: 94981.0218978102
Net tangible assets: 9007801.459854014
Owner earnings: -1722662.7737226274
Return on net tangible assets (%): -19.124120146299784
Buffett classification: The Gruesome
Stock price: 0.6496350364963503
Shares outstanding: 126619532
Book value: 9007801.459854014
P/B ratio: 9.13169374997569
Market cap (USD): 82256484.2919708
Debt to equity: 0.15405461996932424
Current ratio: 0.9963943159075109
Quick ratio: 0.744741398043752
Interest coverage ratio: -36.05412265989756
COGS to revenue (%): 138.15563725490196
R&D to revenue (%): 1140.6602328431372
SG&A to revenue (%): 2673.34712009804
Free cash flow (dilution-adjusted): -1921428.4671532845
Buyback yield (%): 0
Retained earnings: -64012474.45255474
Inventory turnover: 0.10756797244366839
Receivables turnover: 0.14660207910853
Capitalized R&D asset: 706570.3139736386
ROCI (R&D-adjusted, %): -13.479837109440144
Rosenberg metric: -0.10544856812558069
FCF margin (%): -4032.4096200980393
Revenue growth (%): 967.5853111013848
Rule of 40 score: -3064.8243089966545
Financial ratios for 2465.HK — annual report dated 2022-12-31
Total revenue: 2021787780.7140806
Gross profit: 356126841.07758623
Operating income: 212070133.86350575
Net income: 147984614.71695402
Capital expenditures: 160289722.74568966
Operating cash flow: -466831074.6364942
Depreciation & amortization: 36781281.659482755
Net tangible assets: 578713862.8074713
Owner earnings: 24476173.63074711
Return on net tangible assets (%): 4.229408556416409
Capex to operating income (%): 75.58335529172466
Buffett classification: The Gruesome
Shares outstanding: 135000000
Book value: 805957504.8821838
Debt to equity: 1.0310417295514966
Current ratio: 1.3071066126300195
Quick ratio: 0.88305538523965
Effective tax rate (%): 11.279155309663045
Interest coverage ratio: 9.78524508605307
COGS to revenue (%): 82.38554785647162
R&D to revenue (%): 4.37439339920919
SG&A to revenue (%): 1.24371657037469
Free cash flow (dilution-adjusted): -636378403.1551725
Retained earnings: 216041251.0847701
Inventory turnover: 3.85498465629404
Receivables turnover: 6.634421245140606
Capitalized R&D asset: 88440951.2255747
ROCI (R&D-adjusted, %): 22.964104238074462
FCF margin (%): -31.476023805545424
Rule of 40 score: -31.476023805545424
Financial ratios for 2465.HK — annual report dated 2023-12-31
Total revenue: 1227774761.7594936
Gross profit: -1565275.8354430378
Operating income: -126269347.04781997
Net income: -173463214.63853726
Capital expenditures: 301557287.6174402
Operating cash flow: 124560586.99578059
Depreciation & amortization: 62438313.080168776
Net tangible assets: 383753271.87623066
Owner earnings: -412582189.17580867
Return on net tangible assets (%): -107.5123573953204
Buffett classification: The Gruesome
Shares outstanding: 135000000
Book value: 588054251.5822787
Debt to equity: 2.2844404270261363
Current ratio: 0.8707324039873152
Quick ratio: 0.703564566683374
Interest coverage ratio: -3.602963389812264
COGS to revenue (%): 100.12748884275808
R&D to revenue (%): 5.564182957984682
SG&A to revenue (%): 2.56304449987334
Free cash flow (dilution-adjusted): -179978819.5021097
Retained earnings: 38020204.144866385
Inventory turnover: 5.428147057398256
Receivables turnover: 4.0137111476568865
Capitalized R&D asset: 127571071.37739384
ROCI (R&D-adjusted, %): -9.21688740390908
Rosenberg metric: -4.044417342376961
FCF margin (%): -14.658944385221481
Revenue growth (%): -39.272817183322154
Rule of 40 score: -53.931761568543635
Financial ratios for 249A.T — annual report dated 2023-03-31
Total revenue: 10318310.810810812
Gross profit: 2806719.2192192194
Operating income: -512139.6396396397
Net income: -262192.1921921922
Capital expenditures: 21463.963963963964
Operating cash flow: -28348.34834834835
Depreciation & amortization: 447267.2672672673
Net tangible assets: -13265.765765765767
Owner earnings: 163611.11111111112
Buffett classification: The Gruesome
Shares outstanding: 300000
Book value: 303603.6036036033
Debt to equity: 11.38721562809101
Current ratio: 1.0968908626478568
Quick ratio: 1.087815151557604
Interest coverage ratio: -4.011113071088375
COGS to revenue (%): 72.79858323529048
Free cash flow (dilution-adjusted): -143198.19819819822
Retained earnings: 281081.0810810811
Inventory turnover: 257.4075122202213
Receivables turnover: 5.6647047913446675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.427663781646086
FCF margin (%): -1.3878065976474083
Rule of 40 score: -1.3878065976474083
Financial ratios for 249A.T — annual report dated 2024-03-31
Total revenue: 12897464.342313787
Gross profit: 4353453.512942419
Operating income: 422338.88008452195
Net income: 183861.59535129424
Capital expenditures: 144717.37982039092
Operating cash flow: 956378.763866878
Depreciation & amortization: 369935.2879027998
Net tangible assets: 235565.24035921818
Owner earnings: 409079.5034337031
Return on net tangible assets (%): 173.6586869989348
Capex to operating income (%): 34.265701465001015
Buffett classification: The Good
Shares outstanding: 300000
Book value: 448151.0829371372
Debt to equity: 6.59651087404962
Current ratio: 1.2007385377299273
Quick ratio: 1.1925544487590747
Effective tax rate (%): 38.15383248561846
Interest coverage ratio: 2.9633971181022103
COGS to revenue (%): 66.2456123105153
Free cash flow (dilution-adjusted): 781735.3407290016
Retained earnings: 428341.25726360275
Inventory turnover: 342.2121131975668
Receivables turnover: 7.823627194546029
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.245030271249464
FCF margin (%): 6.061155278129339
Revenue growth (%): 24.99588914108612
Rule of 40 score: 31.057044419215458
Financial ratios for 2560.HK — annual report dated 2022-12-31
Total revenue: 264308764.3678161
Gross profit: 52247701.14942529
Operating income: 20249425.28735632
Net income: 13273419.540229885
Capital expenditures: 39184195.40229885
Operating cash flow: -17562356.32183908
Depreciation & amortization: 6719252.873563219
Net tangible assets: 79140086.20689656
Owner earnings: -19191522.98850575
Return on net tangible assets (%): -24.25006581157013
Capex to operating income (%): 193.50769143440996
Buffett classification: The Gruesome
Shares outstanding: 185370800
Book value: 92885201.14942527
Debt to equity: 1.7132398322611186
Current ratio: 0.8213169088612915
Quick ratio: 0.7110255127377695
Effective tax rate (%): 15.7427675020977
Interest coverage ratio: 5.93514697212162
COGS to revenue (%): 80.22987743457915
R&D to revenue (%): 2.1713002197773523
SG&A to revenue (%): 2.2668106843430786
Free cash flow (dilution-adjusted): -57479885.05747127
Retained earnings: 19224856.32183908
Inventory turnover: 12.444665548032413
Receivables turnover: 4.123353932294643
Capitalized R&D asset: 5738936.781609195
ROCI (R&D-adjusted, %): 15.182098259277819
FCF margin (%): -21.747248977896692
Rule of 40 score: -21.747248977896692
Financial ratios for 2560.HK — annual report dated 2023-12-31
Total revenue: 336915752.46132207
Gross profit: 64574120.95639943
Operating income: 29972292.545710266
Net income: 20243881.856540084
Capital expenditures: 12224050.632911392
Operating cash flow: 23022784.81012658
Depreciation & amortization: 9762869.198312236
Net tangible assets: 115670323.488045
Owner earnings: 17782700.42194093
Return on net tangible assets (%): 15.373606544619756
Capex to operating income (%): 40.78450326837257
Buffett classification: The Good
Shares outstanding: 185370800
Book value: 133399156.11814344
Debt to equity: 1.0048551980667773
Current ratio: 0.9849453302214826
Quick ratio: 0.8912830558276199
Effective tax rate (%): 15.34738191720236
Interest coverage ratio: 7.036585768532277
COGS to revenue (%): 80.83374835262043
R&D to revenue (%): 1.913736380027143
SG&A to revenue (%): 8.85061852136803
Free cash flow (dilution-adjusted): 10117158.93108298
Retained earnings: 28490998.593530238
Inventory turnover: 18.81832317754648
Receivables turnover: 4.19009128929734
Capitalized R&D asset: 10292766.968572676
ROCI (R&D-adjusted, %): 17.4283359358269
Rosenberg metric: 2.147857743698271
FCF margin (%): 3.002875008714361
Revenue growth (%): 27.470518530541423
Rule of 40 score: 30.473393539255785
Financial ratios for 2560.HK — annual report dated 2024-12-31
Total revenue: 326595753.4246575
Gross profit: 62969863.01369863
Operating income: 28947534.246575344
Net income: 20258082.191780824
Capital expenditures: 13211095.89041096
Operating cash flow: 22846575.342465755
Depreciation & amortization: 10073698.630136987
Net tangible assets: 130221506.84931508
Owner earnings: 17120684.93150685
Return on net tangible assets (%): 13.147355875184221
Capex to operating income (%): 45.638069819276254
Buffett classification: The Good
Shares outstanding: 185370800
Book value: 150190136.98630133
Debt to equity: 0.8506769501307934
Current ratio: 1.075061416603861
Quick ratio: 0.9831004695924401
Effective tax rate (%): 17.923386872981162
Interest coverage ratio: 7.979043951064795
COGS to revenue (%): 80.71932584750367
R&D to revenue (%): 2.3071125168770914
SG&A to revenue (%): 8.97548768973751
Free cash flow (dilution-adjusted): 9618219.178082192
Retained earnings: 43316986.30136986
Inventory turnover: 18.956737162501604
Receivables turnover: 4.391547168421149
Capitalized R&D asset: 13748725.792459674
ROCI (R&D-adjusted, %): 14.998598331136343
Rosenberg metric: -0.24881168275642326
FCF margin (%): 2.944992112489614
Revenue growth (%): -3.0630800018319957
Rule of 40 score: -0.11808788934238157
Financial ratios for 2560.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 130221506.84931508
Buffett classification: The Gruesome
Shares outstanding: 185370800
Book value: 150190136.98630133
Debt to equity: 0.8506769501307934
Current ratio: 1.075061416603861
Quick ratio: 0.9831004695924401
Retained earnings: 43316986.30136986
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3881.HK — annual report dated 2022-12-31
Total revenue: 4462068.9655172415
Gross profit: -861350.5747126436
Operating income: -28930172.413793102
Net income: -37786925.287356324
Capital expenditures: 21922557.47126437
Operating cash flow: -29174281.609195404
Depreciation & amortization: 3409051.724137931
Net tangible assets: -86852298.85057472
Owner earnings: -56300431.03448276
Buffett classification: The Gruesome
Shares outstanding: 424438920
Book value: -86482327.58620688
Debt to equity: -0.2576817069463066
Current ratio: 3.0224083285135914
Quick ratio: 2.451141700404858
Interest coverage ratio: -133.7011952191235
COGS to revenue (%): 119.30383822771766
R&D to revenue (%): 355.8314013395157
SG&A to revenue (%): 102.76919113858835
Free cash flow (dilution-adjusted): -51217241.37931035
Retained earnings: -87438505.74712643
Inventory turnover: 0.3000931438059369
Receivables turnover: 1.11965966038144
Capitalized R&D asset: 15877442.528735632
ROCI (R&D-adjusted, %): -10.312066486456947
FCF margin (%): -1147.8361669242659
Rule of 40 score: -1147.8361669242659
Financial ratios for 3881.HK — annual report dated 2023-12-31
Total revenue: 18650351.617440224
Gross profit: 3772573.839662447
Operating income: -25570604.781997185
Net income: -35876090.0140647
Capital expenditures: 4155274.2616033754
Operating cash flow: -27673839.662447255
Depreciation & amortization: 4222925.457102672
Net tangible assets: -120856258.790436
Owner earnings: -35808438.818565406
Buffett classification: The Gruesome
Shares outstanding: 424438920
Book value: -120533895.9212377
Debt to equity: -0.18754113204729075
Current ratio: 1.907885139447478
Quick ratio: 1.4666298588809756
Interest coverage ratio: -50.8978163493841
COGS to revenue (%): 79.7721034056288
R&D to revenue (%): 68.1698892944406
SG&A to revenue (%): 32.38439262767338
Free cash flow (dilution-adjusted): -31951195.499296762
Retained earnings: -121469901.54711673
Inventory turnover: 0.6071447020266664
Receivables turnover: 2.6353193688143404
Capitalized R&D asset: 23351810.544885784
ROCI (R&D-adjusted, %): -14.74682256573005
Rosenberg metric: 0.29185584554870403
FCF margin (%): -171.31685318693252
Revenue growth (%): 317.97542264742384
Rule of 40 score: 146.65856946049132
Financial ratios for 3881.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -153355616.43835616
Buffett classification: The Gruesome
Shares outstanding: 424438920
Book value: -153133561.64383566
Debt to equity: -0.21624510790562443
Current ratio: 1.82347216663135
Quick ratio: 1.570909100421967
Retained earnings: -121309589.0410959
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 3881.HK — annual report dated 2024-12-31
Total revenue: 56169178.08219178
Gross profit: 13895890.410958905
Operating income: -61587671.23287671
Net income: -79549178.08219178
Capital expenditures: 188904.1095890411
Operating cash flow: -20237671.232876714
Depreciation & amortization: 4746986.301369864
Net tangible assets: -153355616.43835616
Owner earnings: -74991095.89041096
Buffett classification: The Gruesome
Shares outstanding: 424438920
Book value: -153133561.64383566
Debt to equity: -0.21624510790562443
Current ratio: 1.82347216663135
Quick ratio: 1.570909100421967
Interest coverage ratio: -63.11806822967851
COGS to revenue (%): 75.26064848122722
R&D to revenue (%): 47.11329520650677
SG&A to revenue (%): 82.96901484019658
Free cash flow (dilution-adjusted): -64350136.98630137
Retained earnings: -121309589.0410959
Inventory turnover: 3.196418213457077
Receivables turnover: 3.135974975526187
Capitalized R&D asset: 40221035.83333832
ROCI (R&D-adjusted, %): -33.81074479678265
Rosenberg metric: 0.7962385594707488
FCF margin (%): -114.56485421976173
Revenue growth (%): 201.16953950437662
Rule of 40 score: 86.60468528461489
Financial ratios for 3881.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -182363598.32635984
Buffett classification: The Gruesome
Shares outstanding: 424438920
Book value: -182176708.50767082
Debt to equity: -0.26327603511541436
Current ratio: 0.35853134685443966
Quick ratio: 0.29753147277415437
Retained earnings: -186896234.30962342
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 504A.T — annual report dated 2023-12-31
Total revenue: 0
Operating income: -13164823.587640528
Net income: -14157816.587711234
Capital expenditures: 430573.42855122674
Operating cash flow: -9948653.043908646
Depreciation & amortization: 375585.09510004945
Net tangible assets: -12402736.335996605
Owner earnings: -14212804.921162412
Buffett classification: The Gruesome
Shares outstanding: 45098744
Book value: -12288170.826557308
Debt to equity: -2.0345448226496563
Current ratio: 2.6097325439235135
Quick ratio: 2.5496600134620935
Interest coverage ratio: -5.4471174381388705
Free cash flow (dilution-adjusted): -10383843.597539417
Retained earnings: -41905479.74262886
Inventory turnover: 0
Capitalized R&D asset: 9548447.995474793
ROCI (R&D-adjusted, %): -31.77303610071405
Rule of 40 score: 0
Financial ratios for 504A.T — annual report dated 2024-12-31
Total revenue: 0
Operating income: -11928192.878527295
Net income: -15239435.632842856
Capital expenditures: 76743.74163959487
Operating cash flow: -8267405.567233581
Depreciation & amortization: 344365.8831772724
Net tangible assets: -12548805.656411236
Owner earnings: -14971813.491305178
Buffett classification: The Gruesome
Shares outstanding: 45098744
Book value: -12460022.931396905
Debt to equity: -2.1262972886341642
Current ratio: 4.52633121240596
Quick ratio: 4.45223810909915
Interest coverage ratio: -3.047540543399543
Free cash flow (dilution-adjusted): -8344149.308873177
Retained earnings: -40027517.67628511
Inventory turnover: 0
Capitalized R&D asset: 15222722.91255764
ROCI (R&D-adjusted, %): -30.740409557818786
Rule of 40 score: 0
Financial ratios for 504A.T — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -3598876.177658143
Net income: -5804865.410497981
Capital expenditures: 0
Net tangible assets: 1990612.3822341857
Owner earnings: -5804865.410497981
Return on net tangible assets (%): -291.61204171667146
Buffett classification: The Gruesome
Shares outstanding: 45098744
Book value: 2127516.8236877546
Debt to equity: 15.05323439264396
Current ratio: 12.86620878203201
Quick ratio: 12.783260231100694
Interest coverage ratio: -1.4954183339345284
Retained earnings: -56383021.534320325
Inventory turnover: 0
Capitalized R&D asset: 2608324.3606998655
ROCI (R&D-adjusted, %): -4.971513110264724
Rule of 40 score: 0
Financial ratios for 504A.T — annual report dated 2025-12-31
Total revenue: 0
Operating income: -14268173.390448181
Net income: -18254101.40016623
Capital expenditures: 273371.26782175055
Operating cash flow: -12756831.404641647
Depreciation & amortization: 409091.49031391856
Net tangible assets: -4162694.201138035
Owner earnings: -18118381.177674063
Buffett classification: The Gruesome
Shares outstanding: 45098744
Book value: -4029505.786075063
Debt to equity: -8.244562915010583
Current ratio: 10.404578545213885
Quick ratio: 10.31447242367163
Interest coverage ratio: -2.6034741219909123
Free cash flow (dilution-adjusted): -13093120.644460073
Retained earnings: -53488555.718943805
Inventory turnover: 0
Capitalized R&D asset: 19851453.04465193
ROCI (R&D-adjusted, %): -26.589505745530516
Rule of 40 score: 0
Financial ratios for 504A.T — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -4162118.790358673
Net income: -4862400.10229525
Capital expenditures: 0
Net tangible assets: -4162694.201138035
Owner earnings: -4862400.10229525
Buffett classification: The Gruesome
Shares outstanding: 45098744
Book value: -4029505.786075063
Debt to equity: -8.244562915010583
Current ratio: 10.404578545213885
Quick ratio: 10.31447242367163
Interest coverage ratio: -3.3705441046271414
Retained earnings: -53488555.718943805
Inventory turnover: 0
Capitalized R&D asset: 5020091.866774722
ROCI (R&D-adjusted, %): -8.185502390945334
Rule of 40 score: 0
Financial ratios for 5135.T — annual report dated 2021-12-31
Total revenue: 79402172.77941944
Gross profit: 9368729.358595515
Operating income: 5916321.918998783
Net income: 4052190.1616547885
Capital expenditures: 88284.37337041543
Operating cash flow: -1291482.7046758214
Depreciation & amortization: 27020.684860073005
Net tangible assets: 11215939.509820962
Owner earnings: 3990926.473144446
Return on net tangible assets (%): 35.58263192887131
Capex to operating income (%): 1.4922172014831092
Buffett classification: The Great
Shares outstanding: 30000000
Book value: 11215939.509820962
Debt to equity: 0.17090893029555848
Current ratio: 2.1843901904439758
Quick ratio: 2.0216134365585416
Effective tax rate (%): 34.61188930837367
Interest coverage ratio: 581.8222222222223
COGS to revenue (%): 88.20091562906974
Free cash flow (dilution-adjusted): -1379767.0780462367
Retained earnings: 10918407.787241438
Inventory turnover: 52.16442896539223
Receivables turnover: 11.16173495318334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 47.0701309908395
FCF margin (%): -1.737694359925455
Rule of 40 score: -1.737694359925455
Financial ratios for 5893.T — annual report dated 2022-11-30
Total revenue: 7438193.743693239
Gross profit: 5851160.443995963
Operating income: 31007.640190283983
Net income: -118711.25846907885
Capital expenditures: 73273.74945942049
Operating cash flow: -627454.2309355629
Depreciation & amortization: 58137.523425111714
Net tangible assets: 339519.9654029119
Owner earnings: -133847.48450338762
Return on net tangible assets (%): -39.42256660651736
Capex to operating income (%): 236.30869363086936
Buffett classification: The Gruesome
Shares outstanding: 1980000
Book value: 339519.9654029119
Debt to equity: 5.43420019106252
Current ratio: 2.3079729301046847
Quick ratio: 2.1733504282542033
Interest coverage ratio: 2.0369318181818183
COGS to revenue (%): 21.33617577945202
Free cash flow (dilution-adjusted): -700727.9803949834
Retained earnings: 268163.47124117054
Inventory turnover: 10.809229258713794
Receivables turnover: 16.404250584177145
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6377715342972659
FCF margin (%): -9.420673950434846
Rule of 40 score: -9.420673950434846
Financial ratios for 6682.HK — annual report dated 2022-12-31
Total revenue: 442907614.9425287
Gross profit: 213598563.2183908
Operating income: -156523850.57471263
Net income: -236335775.86206898
Capital expenditures: 2133908.0459770113
Operating cash flow: -112009913.79310344
Depreciation & amortization: 11615660.91954023
Net tangible assets: -291956609.1954023
Owner earnings: -226854022.98850578
Buffett classification: The Gruesome
Shares outstanding: 319554296
Book value: -209915373.56321847
Debt to equity: -0.09896297837593279
Current ratio: 3.170742352729563
Quick ratio: 3.10781769688655
Interest coverage ratio: -1.6169531273191438
COGS to revenue (%): 51.773562699727535
R&D to revenue (%): 53.525926017237836
SG&A to revenue (%): 30.486560694626057
Free cash flow (dilution-adjusted): -176510344.8275862
Retained earnings: -600238218.3908046
Inventory turnover: 16.351864184502524
Receivables turnover: 2.0643976378849187
Capitalized R&D asset: 237070402.29885057
ROCI (R&D-adjusted, %): 0.15548321314699104
FCF margin (%): -39.852632664825606
Rule of 40 score: -39.852632664825606
Financial ratios for AMRZ — annual report dated 2022-12-31
Total revenue: 11658695652.173912
Gross profit: 2686956521.7391305
Operating income: 1869565217.3913043
Net income: 1204347826.0869565
Capital expenditures: 484782608.6956521
Operating cash flow: 2160869565.217391
Depreciation & amortization: 856521739.1304348
Net tangible assets: -1466304347.826087
Owner earnings: 1576086956.521739
Return on net tangible assets (%): -107.48702742772423
Capex to operating income (%): 25.930232558139533
Buffett classification: The Good
Shares outstanding: 553536609
Book value: 8923913043.47826
Debt to equity: 1.0548112058465289
Current ratio: 1.4024877832074634
Quick ratio: 0.8569524655708574
Effective tax rate (%): 25.068493150684933
Interest coverage ratio: 6.935483870967743
COGS to revenue (%): 76.95319783703152
SG&A to revenue (%): 7.0110013052396045
Free cash flow (dilution-adjusted): 1626086956.521739
Inventory turnover: 6.721498371335505
Receivables turnover: 7.607092198581561
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.338183397578588
FCF margin (%): 13.947417490210704
Rule of 40 score: 13.947417490210704
Financial ratios for AMRZ — annual report dated 2023-12-31
Total revenue: 13901190476.190477
Gross profit: 3296428571.4285717
Operating income: 2227380952.3809524
Net income: 1138095238.0952382
Capital expenditures: 691666666.6666667
Operating cash flow: 2423809523.809524
Depreciation & amortization: 1013095238.0952381
Net tangible assets: -1965476190.4761906
Owner earnings: 1459523809.5238097
Return on net tangible assets (%): -74.2580254391278
Capex to operating income (%): 31.052912880812407
Buffett classification: The Good
Shares outstanding: 553536609
Book value: 10955952380.952381
Debt to equity: 1.0348799304574594
Current ratio: 1.6123618501841996
Quick ratio: 1.0773638968481374
Effective tax rate (%): 27.705295471987725
Interest coverage ratio: 3.4080145719489985
COGS to revenue (%): 76.28671747880449
SG&A to revenue (%): 7.69033142074163
Free cash flow (dilution-adjusted): 1667857142.857143
Inventory turnover: 6.815608263198165
Receivables turnover: 8.352646638054363
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.080761017278197
FCF margin (%): 11.997944677571294
Revenue growth (%): 19.23452580733955
Rule of 40 score: 31.232470484910845
Financial ratios for AMRZ — annual report dated 2024-12-31
Total revenue: 13004444444.444445
Gross profit: 3411111111.111111
Operating income: 2362222222.2222223
Net income: 1415555555.5555556
Capital expenditures: 645555555.5555556
Operating cash flow: 2535555555.5555553
Depreciation & amortization: 972222222.2222222
Net tangible assets: -926666666.6666666
Owner earnings: 1742222222.222222
Return on net tangible assets (%): -188.00959232613909
Capex to operating income (%): 27.328316086547506
Buffett classification: The Good
Shares outstanding: 553536609
Book value: 11015555555.555555
Debt to equity: 0.9626790397417794
Current ratio: 1.8749019607843136
Quick ratio: 1.3054901960784315
Effective tax rate (%): 22.604422604422606
Interest coverage ratio: 4.152343750000001
COGS to revenue (%): 73.76965140123035
SG&A to revenue (%): 8.065618591934381
Free cash flow (dilution-adjusted): 1815555555.5555553
Retained earnings: 0
Inventory turnover: 5.946280991735538
Receivables turnover: 7.310430980637102
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.002352387673488
FCF margin (%): 13.96103896103896
Revenue growth (%): -6.450857811652543
Rule of 40 score: 7.510181149386418
Financial ratios for AMRZ — quarterly report dated 2025-03-31
Total revenue: 2364772727.2727275
Gross profit: 252272727.27272728
Operating income: -19318181.818181816
Net income: -98863636.36363636
Capital expenditures: 237500000
Operating cash flow: -972727272.7272727
Depreciation & amortization: 244318181.8181818
Net tangible assets: 1973863636.3636363
Owner earnings: -92045454.54545456
Return on net tangible assets (%): -4.663212435233162
Buffett classification: The Gruesome
Shares outstanding: 553536609
Book value: 14168181818.181818
Debt to equity: 0.4778633301251203
Current ratio: 1.6651162790697673
Quick ratio: 0.8361757105943153
Interest coverage ratio: -0.14406779661016947
COGS to revenue (%): 89.3320518981259
SG&A to revenue (%): 11.484863046612205
Free cash flow (dilution-adjusted): -1213636363.6363637
Inventory turnover: 1.1589775561097257
Receivables turnover: 1.4917562724014337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08345196603014089
FCF margin (%): -51.32148005766458
Rule of 40 score: -51.32148005766458
Financial ratios for AUBANK.NS — annual report dated 2023-03-31
Total revenue: 665092472.5943971
Net income: 173925127.89281365
Capital expenditures: 36985274.05602924
Operating cash flow: 669140048.721072
Depreciation & amortization: 22584372.71619976
Net tangible assets: 1337069878.1973205
Owner earnings: 159524226.55298418
Return on net tangible assets (%): 11.930881785180873
Buffett classification: The Gruesome
Shares outstanding: 748662402
Book value: 1337069878.197321
Debt to equity: 0.5737865436426116
Effective tax rate (%): 23.421065079262757
COGS to revenue (%): 0
SG&A to revenue (%): 9.739881765637639
Free cash flow (dilution-adjusted): 629347892.813642
Retained earnings: 522184725.9439708
Receivables turnover: 7.588892417443971
Capitalized R&D asset: 0
FCF margin (%): 94.6256225632321
Rule of 40 score: 94.6256225632321
Financial ratios for AUBANK.NS — annual report dated 2024-03-31
Total revenue: 822115541.4318264
Net income: 184041132.03021944
Capital expenditures: 40567502.09857297
Operating cash flow: 312755702.1225567
Depreciation & amortization: 27034884.27869049
Net tangible assets: 1506119618.6593118
Owner earnings: 170508514.21033695
Return on net tangible assets (%): 11.321047285880049
Buffett classification: The Gruesome
Shares outstanding: 748662402
Book value: 1506119618.6593113
Debt to equity: 0.43627201380879543
Effective tax rate (%): 23.242098431744772
COGS to revenue (%): 0
SG&A to revenue (%): 11.679543568734067
Free cash flow (dilution-adjusted): 267576136.22736537
Retained earnings: 620324187.5524644
Receivables turnover: 7.114378562704111
Capitalized R&D asset: 0
FCF margin (%): 32.547266502387856
Revenue growth (%): 23.609208539815928
Rule of 40 score: 56.15647504220378
Financial ratios for AUBANK.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1916056509.7945533
Buffett classification: The Gruesome
Shares outstanding: 748662402
Book value: 1916056509.7945538
Debt to equity: 0.5471599485253777
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUBANK.NS — quarterly report dated 2024-12-31
Total revenue: 307858316.8201422
Net income: 61597657.06958853
Capital expenditures: 0
Owner earnings: 61597657.06958853
Buffett classification: The Gruesome
Shares outstanding: 748662402
Effective tax rate (%): 24.854393258078655
COGS to revenue (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUBANK.NS — quarterly report dated 2025-03-31
Total revenue: 333714285.7142857
Net income: 58884568.62286649
Capital expenditures: 0
Net tangible assets: 2006813385.5506194
Owner earnings: 58884568.62286649
Return on net tangible assets (%): 2.934232402815573
Buffett classification: The Gruesome
Shares outstanding: 748662402
Book value: 2006813385.550621
Debt to equity: 0.6792328474954475
Effective tax rate (%): 23.35094120953677
COGS to revenue (%): 0
Retained earnings: 811165068.9735795
Receivables turnover: 1.7892101911682365
Capitalized R&D asset: 0
Revenue growth (%): 8.398658565150638
Rule of 40 score: 8.398658565150638
Financial ratios for AUBANK.NS — annual report dated 2025-03-31
Total revenue: 1231925718.961889
Net income: 246192027.12181434
Capital expenditures: 30048246.434416644
Operating cash flow: 638579822.3053541
Depreciation & amortization: 30221381.80967968
Net tangible assets: 2006813385.5506194
Owner earnings: 246365162.49707735
Return on net tangible assets (%): 12.276436078757811
Buffett classification: The Gruesome
Shares outstanding: 748662402
Book value: 2006813385.550621
Debt to equity: 0.6792328474954475
Effective tax rate (%): 24.466078330402556
COGS to revenue (%): 0
SG&A to revenue (%): 8.068580049866897
Free cash flow (dilution-adjusted): 600918622.8664951
Retained earnings: 811165068.9735795
Receivables turnover: 6.604973612115617
Capitalized R&D asset: 0
FCF margin (%): 48.77880326850171
Revenue growth (%): 49.84824600400113
Rule of 40 score: 98.62704927250284
Financial ratios for AUBANK.NS — quarterly report dated 2025-06-30
Total revenue: 334106857.0091271
Net income: 67968429.67470162
Capital expenditures: 0
Owner earnings: 67968429.67470162
Buffett classification: The Gruesome
Shares outstanding: 748662402
Effective tax rate (%): 25.42625256706728
COGS to revenue (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.11763694622816188
Rule of 40 score: 0.11763694622816188
Financial ratios for AUBANK.NS — quarterly report dated 2025-12-31
Total revenue: 341435479.5588727
Net income: 74374111.61858082
Capital expenditures: 0
Owner earnings: 74374111.61858082
Buffett classification: The Gruesome
Shares outstanding: 748662402
Effective tax rate (%): 24.487685554196716
COGS to revenue (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.193496600264453
Rule of 40 score: 2.193496600264453
Financial ratios for BMW.TO — annual report dated 2022-12-31
Total revenue: 104860294117.64705
Gross profit: 18064705882.35294
Operating income: 10447794117.647058
Net income: 13663235294.117645
Capital expenditures: 6654411764.705882
Operating cash flow: 17296323529.411762
Depreciation & amortization: 6298529411.764706
Net tangible assets: 48050735294.117645
Owner earnings: 13307352941.176468
Return on net tangible assets (%): 27.69437940901926
Capex to operating income (%): 63.692026180589764
Buffett classification: The Good
Shares outstanding: 2984863017
Book value: 67123529411.76471
Debt to equity: 0.7839036894224869
Current ratio: 1.0921927008682673
Quick ratio: 0.85829355255209
Effective tax rate (%): 20.957931005146964
Interest coverage ratio: 61.778260869565216
COGS to revenue (%): 82.77259659210434
SG&A to revenue (%): 7.44407825538181
Free cash flow (dilution-adjusted): 10641911764.705881
Inventory turnover: 5.9780208649853135
Receivables turnover: 3.6133985354853424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.743730962124243
FCF margin (%): 10.148657176916064
Rule of 40 score: 10.148657176916064
Financial ratios for BMW.TO — annual report dated 2023-12-31
Total revenue: 117801515151.51515
Gross profit: 22491666666.666664
Operating income: 13996969696.969696
Net income: 9215909090.90909
Capital expenditures: 8243181818.181818
Operating cash flow: 13289393939.393938
Depreciation & amortization: 6798484848.484848
Net tangible assets: 52707575757.57575
Owner earnings: 7771212121.21212
Return on net tangible assets (%): 14.744013568287004
Capex to operating income (%): 58.89261744966443
Buffett classification: The Good
Shares outstanding: 2984863017
Book value: 70396212121.21213
Debt to equity: 0.7699708360685729
Current ratio: 1.0916196365559017
Quick ratio: 0.8191170216434294
Effective tax rate (%): 28.84300421151147
Interest coverage ratio: 28.164634146341463
COGS to revenue (%): 80.90714993118883
SG&A to revenue (%): 7.090123345637886
Free cash flow (dilution-adjusted): 5046212121.212121
Inventory turnover: 5.306605365277544
Receivables turnover: 3.7926341463414635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.273483882383807
FCF margin (%): 4.283656381432559
Revenue growth (%): 12.341393034191587
Rule of 40 score: 16.625049415624147
Financial ratios for BMW.TO — annual report dated 2024-12-31
Total revenue: 99566433566.43356
Gross profit: 16010489510.489511
Operating income: 7967832167.832169
Net income: 5369230769.230769
Capital expenditures: 8534965034.965035
Operating cash flow: 5290909090.909091
Depreciation & amortization: 6048951048.951049
Net tangible assets: 50416083916.083916
Owner earnings: 2883216783.2167826
Return on net tangible assets (%): 5.718843193009223
Capex to operating income (%): 107.1177812883974
Buffett classification: The Gruesome
Shares outstanding: 2984863017
Book value: 66435664335.66434
Debt to equity: 0.9000136837784071
Current ratio: 1.0991914607305362
Quick ratio: 0.8210836022762262
Effective tax rate (%): 30.01549539695561
Interest coverage ratio: 19.884816753926703
COGS to revenue (%): 83.91979210563282
SG&A to revenue (%): 7.93369855316758
Free cash flow (dilution-adjusted): -3244055944.055944
Inventory turnover: 4.899536638372903
Receivables turnover: 3.4388812404898195
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.328488194486874
FCF margin (%): -3.2581823289787892
Revenue growth (%): -15.47949664452771
Rule of 40 score: -18.7376789735065